Background
Noninvasive brain stimulation methods, including repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), have received considerable attention in recent years [1] [2] [3] . These methods are considered a new alternative to standard pharmacotherapy, and have been used to treat a wide range of neurological and psychiatric diseases, including post-stroke disorders, depression, Alzheimer's disease, and Parkinson's disease [4] [5] [6] [7] [8] [9] . In these treatments, stimulation with magnetic (rTMS) or direct electrical (tDCS) energy interacts with the cortical neurons, resulting in excitement or inhibition of neuronal activity in a specific brain region [10] [11] [12] [13] . Among these two methods, rTMS offers better spatial and temporal resolution than tDCS 14, 15 , but carries a greater risk of inducing seizures and requires a higher degree of both technical and clinical expertise 16, 17 . In contrast, tDCS is less expensive than rTMS; a typical tDCS apparatus is batteryoperated, highly portable, and easy to use. In some clinical settings, the effects of tDCS appear to last longer than those of rTMS 18, 19 . Furthermore, tDCS has been shown to confer polarity-dependent effects on brain excitability. Specifically, anodal stimulation facilitates the depolarization of neurons, while cathodal stimulation hyperpolarizes the resting membrane potential and reduces neuronal firing [20] [21] [22] [23] . Taking these findings together, this ability to modulate the excitatory/ inhibitory balance of the brain in a convenient, easy-to-use system makes tDCS a promising approach for the treatment of neuropsychiatric symptoms.
Safety
The safety of tDCS has been well established in recent years 24 . To date, no severe adverse effects have been reported using standard tDCS protocols, although significant care should still be used when applying tDCS in clinical settings. During tDCS, mild tingling and itching sensations under the electrode are the most common side effects, with some patients complaining of a hot or burning sensation, and pain [25] [26] [27] [28] . With high current amplitudes, redness and slight burning of the skin under the electrode are common 29, 30 ; other symptoms such as headache, fatigue, nausea, insomnia, and mood changes after tDCS have also been noted 25 . But thus far, seizure incidents have not been reported in tDCS studies. Overall, tDCS is considered safe when following established protocols 24, 31, 32 ; however, the effects of tDCS on cerebral blood vessels and blood-brain barrier (BBB) functions remain poorly understood.
Effects on BBB integrity
The BBB is a highly selective interface that separates the brain from circulating blood, preventing many viruses, bacteria, and toxins from entering the central nervous system. Maintenance of the BBB is therefore of critical importance, both during and after tDCS therapy.
To date, only a small number of studies have investigated the safety of tDCS with respect to blood-brain barrier disturbance. Nitsche et al. applied weak tDCS stimulation to healthy human subjects and used MRI to test for the possibility of structural changes in brain tissue or alteration of the BBB 33 . In this study, 1 mA current was applied to the frontal cortex through saline-soaked sponge electrodes (0.03 mA/cm 2 ) for 9-13 min. Subsequent MRI scans performed 30 and 60 min after tDCS revealed no evidence of brain edema, structural changes in cerebral tissue, or alterations of the BBB 33 . However, given the weak stimulus conditions used in this study (1 mA for up to 13 min) 33 , these results alone are insufficient to establish the safety of tDCS in the context of cerebral tissues or BBB integrity, as conventional tDCS protocols employ current intensities up to 4 mA, with durations ranging up to 40 min 24 . The relationship between stimulus intensity and outcome is not clear yet, but a couple of studies suggested that stronger stimulation may result in greater benefits. Iyer et al. examined the effects of tDCS on cognitive function in healthy human subjects and found that verbal fluency significantly improved following stimulation at 2 mA, compared with no significant effects after stimulation with 1 mA ) using a rat model of Alzheimer's disease 35 . Given these apparent intensity-dependent effects of tDCS treatment, it is important to determine the effect of tDCS on the BBB integrity when using relatively high current stimulations.
A recent study reported by Nik-Mohd-Afizan et al. investigated the effect of high current tDCS in rats, and found that anodal, but not cathodal, tDCS had negligible effects on BBB permeability 36 . Here, anodal stimulation was applied at a charge density of 260,820 C/m 2 , an intensity five times higher than the threshold estimate for cathodal tDCS-induced brain damage in rats 37 . 36 . Further validation of these results was performed by immunohistochemical staining of brain tissues obtained after tDCS stimulation for claudin-5 (CLDN5), a key component sealing the paracellular space between adjacent endothelial cells 38 . These analyses revealed significantly decreases in CLDN5 levels following cathodal, but not anodal, stimulation, indicating that anodal stimulation did not affect tight junction permeability 36 . Taken together, these findings reveal polarity-specific effects of brain stimulation on the BBB permeability, and suggest that anodal tDCS may be used safely at increasing stimulus intensity.
Despite the strong evidence reported by Nik-MohdAfizan et al., a different study using a mouse ischemic stroke model reported that anodal tDCS exacerbated dysregulation of BBB during the acute phase of stroke 39 . In this study, Peruzzotti-Jametti et al. evaluated the ratio of endogenous immunoglobulin G (IgG) extravasation in the ipsilateral ischemic hemisphere, and found a significant increase in endogenous IgG leakage only in the anodal tDCS group 39 . They also analyzed the endothelial tight junction protein zona occludens-1 (ZO-1) and confirmed a significant decrease in its expression in the anodal tDCS condition. As ZO-1 is fundamental for maintaining the BBB after ischemic stroke 40, 41 , these results suggest that the disruption of blood vessel tight junctions occurs in the case of anodal stimulation, but not cathodal stimulation 39 . To put these results in context, these findings were obtained using a charge density of 132,000 C/m 2 for tDCS stimulation, which was about half of that used by Nik-Mohd-Afizan et al. 36 .
Discrepancies in the polarity effects of high-intensity tDCS on BBB disruption mark an important distinction between these two studies. One possible explanation for this discrepancy could be that Nik-Mohd-Afizan et al. performed tDCS on normal healthy brains 36 , whereas Peruzzotti-Jametti et al. 39 applied tDCS to the ischemic brain in the acute phase of stroke. These findings suggest that the safety of tDCS may differ between healthy and injured brains, with the severity of brain damage or post-acute/ chronic stages of brain injury affecting patient outcomes. Further animal studies will be necessary to resolve this issue.
Potential for drug delivery
While maintenance of the BBB is of crucial importance for long-term neuronal health, it represents a formidable obstacle to drug delivery, limiting the effectiveness of many drugs used to treat neurological disorders, such as brain tumors, Alzheimer's disease, and Parkinson's disease. Therefore, methods capable of temporarily improving the permeability of drugs across the BBB may hold considerable promise for the treatment of neurological disorders. Existing treatments, such as the administration of hyperosmotic agents (e.g., mannitol) or blood vessel dilators (e.g., bradykinin), have been shown to increase BBB permeability, providing an enhanced therapeutic window lasting several hours 42, 43 . On top of that, direct targeting methods using lasers, focused ultrasound, or hyperthermia have also been evaluated as an alternative way to create a transient opening in the BBB 44, 45 .
Considerable evidence indicates that electrical brain stimulation methods, such as tDCS affect a range of cerebrovascular functions 46 including BBB integrity, as described above. Assuming that the correct stimulus parameters can be identified, tDCS may become a viable and feasible option for modulating drug delivery to the CNS. Recent work by Shin et al. provides an important proof of concept, having shown that brief exposure (20 min, 1 mA) of the rat frontal cortex to tDCS was able temporarily to increase the permeability of cerebral microvessels to small and large molecules (molecular weight ranging from 376 to 70,000), with BBB permeability returning to baseline levels within 20 min post-treatment 47 . These results highlight the considerable potential of tDCS for drug delivery; however, more research will be needed to evaluate the overall efficacy of this procedure, and the safety of tDCS on the cortical vasculature.
Future perspective
In clinical MRI, gadolinium-based contrast agents have been used as a reliable marker of impaired BBB 48 . However, as an alternative approach, recent studies have reported several biomarkers specific to BBB disruption in serum of patients (e.g. astrocyte-derived protein S-100β 49 and tight junction protein CLDN5 50 ). Assuming such proteins circulating in the blood mirror BBB integrity, accumulated evidence from animal studies may be useful in clinical trials. Therefore, future studies examining tDCS effects on BBB permeability in animal models of human diseases should combine measurement of serum levels of candidate clinical biomarkers.
Conclusion
Here, we have presented a brief summary focusing the effects of tDCS on BBB permeability. Although tDCS is a convenient technique capable of modulating brain functions, its effects on cerebrovascular and other neurological functions remain poorly understood. Furthermore, additional research will be necessary to assess both the efficacy of this procedure and the safety of tDCS on the cortical vasculature. Further advances in our understanding of tDCS and its effects on BBB function may unlock the potential of this method for improving drug delivery to the CNS. Given the clear benefits of electrical brain stimulation methods for the treatment of neurological symptoms, a combination of drug therapy and electrical brain stimulation may offer considerable promise for the treatment of neurological disorders in future.
